Rat beta-adrenergic receptor kinases 1 and 2 in mouse neuroblastoma X rat glioma NG 108-15 hybrid cells

Biochemical Pharmacology

Volumn 55, Issue 1, 1998, Pages 65-70

  Schulz, Karin ^a   Müller, Stefan ^b   Belke Louis, Georg ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

ARK; opioid receptor phosphorylation; NG 108 15 cells; Rat beta adrenergic receptor kinase

Indexed keywords

BETA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOTRANSFERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HYBRID CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ANIMALS; BETA-ADRENERGIC RECEPTOR KINASE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLIOMA; HYBRID CELLS; ISOENZYMES; MICE; NEUROBLASTOMA; PHOSPHORYLATION; RATS; RECEPTORS, OPIOID; RNA, MESSENGER;

EID: 0031952056     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00380-8     Document Type: Article

References (27)

1. 1. Hausdorff WP, Caron MG and Lefkowitz RJ, Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 4: 2881-2889, 1990.
2. 2. Chuang TT, Iacovelli L, Sallese M and De Blasi A, G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharm Sci 17: 416-421, 1996.
3. 3. Kieffer B, Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cel Mol Neurobiol 15: 615-635, 1995.
4. 4. Nestler E, Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol 7: 23-39, 1993.
5. 5. Raynor K, Kong H, Hines J, Benovic J, Yasuda K, Bell GI and Reisine T, Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J Pharm Exp Ther 270: 1381-1386, 1994.
6. 6. Pei G, Kieffer BL, Lefkowitz RJ and Freedman NJ, Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharm 48: 173-177, 1995.
7. 7. Terwilliger RZ, Ortiz J, Guitart X and Nestler EJ, Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J Neurochem 63: 1983-1986, 1994.
8. 8. Sterne-Marr R and Benovic JL, Regulation of G protein-coupled receptors by receptor kinases and arrestins. Adv Res Appl 51: 194-234, 1995.
9. 9. Hamprecht B, Structural, electrophysiological, biochemical and pharmacological properties of neuroblastoma × glioma hybrids in the cell culture. Int Rev Cytol 49: 99-170, 1977.
10. 10. Childers, SR, Opioid receptor-coupled second messenger systems. Life Sci 48: 1991-2003, 1991.
11. 11. Polastron J, Jauzac P and Meunier J-C, The delta opioid receptor in neuroblastoma × glioma NG 108-15 hybrid cells is strongly precoupled to a G-protein. Eur J Pharm 226: 133-139, 1992.
12. 12. Law P, Hom D and Loh H, Down-regulation of opiate receptors in neuroblastoma × glioma NG 108-15 hybrid cells. J Biol Chem 259: 4096-4104, 1984.
13. 13. Arriza JL, Dawso TM, Simerly RB, Martin LJ, Caron MG, Snyder SH and Lefkowitz RL, The G-protein-coupled receptor kinases βARK1 and βARK2 are widely distributed at synapses in rat brain. J Neurosci 12: 4045-4055, 1992.
14. 14. Marra et al., Wisconsin Database: Accession W48962, 1996.
15. 15. Benovic JL, Strasser RH, Caron MG and Lefkowitz RJ, β-Adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptors. Proc Natl Acad Sci 83: 2797-2801, 1986.
16. 16. Pei G, Tiberi M, Caron MG and Lefkowitz RJ, An approach to the study of G-protein-coupled receptor kinases: an in vitro-purified membrane assay reveals differential receptor specificity and regulation by Gβγ subunits. Proc Natl Acad Sci USA 91: 3633-3636, 1994.
17. 17. Ferguson SSG, Barak LS, Zhang J and Caron MG, G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can Physiol Pharmacol 74: 1095-1110, 1996.
18. 1 receptor number. Eur J Pharmacol 302: 199-205, 1996.
19. 19. Ammer H and Schulz R, Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor. J Pharm Exp Ther 280: 512-520, 1997.
20. 20. Obermeier H, Wehmeyer A and Schulz R, Expression of μ-, δ-and κ-opioid receptors in baculovirus-infected insect cells. Eur J Pharmacol 318: 161-166, 1996.
21. 21. Söhlemann P, Hekman M, Elce JS, Buchen C and Lohse MJ, Purification and characterization of the β-adrenergic receptor kinase expressed in insect cells. FEBS Lett 324: 59-62, 1993.
22. 22. Müller S, Straub A and Lohse MJ, Selectivity of β-adrenergic receptor kinase 2 for G protein β γ subunits. FEBS Lett 401: 25-29, 1997.
23. 4. Nature 227: 680-685, 1970.
24. 24. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ, Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-269, 1951.
25. 25. Wehmeyer A and Schulz R, Overexpression of δ-opioid receptors in recombinant baculovirus-infected Trichoplusia ni "High 5" insect cells. J Neurochem 68: 1361-1371, 1997.
26. 26. Schulz K, Danner S, Bauer P, Schröder S and Lohse M, Expression of phosducin in a phosducin-negative cell line reveals functions of a Gβγ-binding protein. J Biol Chem 271: 22546-22551, 1996.
27. 27. Ungerer M, Parruti G, Böhm M, Puzicha M, DeBlasi A, Erdmann E and Lohse MJ, Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circulation 87: 454-463, 1993.